Fatty Liver Urine Colour: Causes and Symptoms

Fatty liver urine colour changes are not typical in early-stage disease, but can become a significant warning sign as liver disease progresses. In simple non-alcoholic fatty liver disease (NAFLD), urine usually remains pale yellow because the liver still processes bilirubin normally. If the condition advances to non-alcoholic steatohepatitis (NASH), cirrhosis, or liver failure, bilirubin metabolism is disrupted, and dark, amber, or tea-coloured urine may appear. Understanding what urine colour changes mean, which accompanying symptoms require urgent attention, and how lifestyle changes can support liver health is essential for anyone managing fatty liver disease.

Can fatty liver disease change the colour of your urine?

Simple fatty liver does not typically change urine colour, but advanced disease such as NASH or cirrhosis can cause dark, amber, or tea-coloured urine due to raised conjugated bilirubin being filtered by the kidneys.

Simple fatty liver disease (hepatic steatosis) does not typically cause changes in urine colour on its own, but more advanced liver disease can. In uncomplicated non-alcoholic fatty liver disease (NAFLD), the liver retains enough function to process bilirubin normally, so urine colour usually remains pale yellow.^[12] However, if fatty liver progresses to non-alcoholic steatohepatitis (NASH), cirrhosis, or liver failure, bilirubin metabolism becomes significantly disrupted.

Bilirubin is a yellow pigment produced when red blood cells break down. A healthy liver conjugates bilirubin (making it water-soluble) and excretes it via bile into the digestive tract. Dark, amber, or tea-coloured urine from liver disease reflects raised conjugated (water-soluble) bilirubin in the blood, a state called conjugated hyperbilirubinaemia. Because conjugated bilirubin is water-soluble, the kidneys can filter and excrete it, darkening the urine. Unconjugated bilirubin, by contrast, is not water-soluble and does not appear in urine, so impaired conjugation alone does not cause dark urine.^[12] Bilirubinuria is therefore a sign of cholestasis or significant hepatocellular damage with a cholestatic component, rather than early-stage fatty liver.^[12][11]

Many other factors can also alter urine colour, including dehydration, certain foods (such as beetroot), vitamin supplements, and some medicines. Dark urine caused by dehydration will typically resolve after drinking adequate fluids. Persistent dark urine despite adequate hydration is more likely to reflect an underlying medical cause and warrants prompt assessment. If you notice persistent dark or unusual urine, particularly alongside other symptoms, seek medical advice rather than attempting to self-diagnose liver disease from urine colour alone.

Relevant UK sources: NHS Jaundice in adults; NICE CKS Jaundice (adult); British Liver Trust patient resources.

What does dark or unusual urine mean for your liver health?

Persistently dark or tea-coloured urine alongside jaundice and pale stools suggests disrupted bile flow from liver cell damage or bile duct obstruction, and requires prompt GP assessment including liver blood tests and abdominal ultrasound.

Persistently dark or tea-coloured urine can be a sign that the liver is struggling to process bilirubin effectively, which may indicate significant liver disease. In the context of liver health, dark urine is often accompanied by jaundice (yellowing of the skin and whites of the eyes) and pale or clay-coloured stools. This triad of symptoms points to a disruption in bile flow, either because liver cells are damaged or because a bile duct is blocked, for example by gallstones or, less commonly, a tumour. New adult jaundice with dark urine and pale stools should be assessed the same day, as it may indicate cholestasis requiring urgent investigation.^[11][10]

For people with known fatty liver disease, the appearance of dark urine is a signal that the condition may have progressed beyond simple steatosis. Advanced fibrosis, cirrhosis, or acute-on-chronic liver failure can all impair bilirubin metabolism sufficiently to cause bilirubinuria. Acute alcoholic hepatitis, viral hepatitis, and drug-induced liver injury can also produce this picture and should be considered in the differential diagnosis.

Foamy or frothy urine is primarily a sign of proteinuria and usually indicates a kidney problem rather than liver disease; a GP can arrange urine dipstick testing and, if proteinuria is confirmed, further renal evaluation. Orange-tinted urine may reflect raised urobilinogen, another breakdown product of bilirubin, but orange or dark urine can also be caused by medicines (for example, rifampicin or nitrofurantoin), foods, and supplements, so non-hepatic causes should always be considered.

A GP can arrange initial investigations, which typically include urine dipstick testing for bilirubin and urobilinogen, liver blood tests (ALT, AST, ALP, GGT, bilirubin with fractionation, albumin, and INR), a full blood count, and hepatitis serology where indicated. First-line imaging is usually an abdominal ultrasound. Where painless obstructive jaundice raises concern about a biliary or pancreatic cause, urgent referral under the two-week-wait pathway (NICE NG12) should be considered.^[2] Early investigation is important because identifying the underlying cause promptly can significantly influence outcomes.

Relevant UK sources: BSG guideline on abnormal liver blood tests; NICE NG12 (Suspected cancer: recognition and referral); NHS Jaundice in adults; NICE CKS Jaundice (adult).

Which symptoms alongside urine changes should you tell your GP about?

Tell your GP promptly if dark urine is accompanied by jaundice, pale stools, abdominal swelling, easy bruising, or confusion; call 999 immediately if you experience vomiting blood or black tarry stools.

You should contact your GP promptly if dark or unusual urine is accompanied by yellowing of the skin or eyes, persistent fatigue, abdominal pain, or swelling of the abdomen or legs. Any new jaundice in an adult with dark urine and pale stools warrants same-day clinical assessment to exclude cholestasis or obstruction. NICE guidance (NG49) on the assessment of NAFLD recommends that GPs use a combination of clinical history, examination, blood tests, and imaging to evaluate liver health.^[1]

The following symptoms alongside urine changes are particularly important to report:

• Jaundice (yellow skin or eyes): indicates raised bilirubin and impaired liver or bile duct function

• Pale or clay-coloured stools: suggests bile is not reaching the gut, pointing to bile duct obstruction or severe liver dysfunction

• Abdominal swelling (ascites): fluid accumulation in the abdomen is a sign of advanced liver disease

• Unexplained weight loss or loss of appetite: may indicate serious underlying pathology

• Easy bruising or bleeding: the liver produces clotting factors, and impaired production raises bleeding risk

• Confusion or difficulty concentrating: hepatic encephalopathy can occur in advanced liver failure

• Itching (pruritus): bile salts depositing in the skin can cause intense itching in cholestatic liver disease^[13][14]

If you experience severe confusion, vomiting blood, or black tarry stools, call 999 or go to your nearest A&E immediately, as these may indicate a life-threatening emergency. For urgent advice that does not require emergency attendance, NHS 111 is available around the clock.

If you suspect that a medicine you are taking has affected your liver or caused a change in urine colour, you can report this to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Relevant UK sources: NICE NG49 (NAFLD: assessment and management); BSG guideline on abnormal liver blood tests; NHS Jaundice in adults; NHS 111.

What lifestyle changes can help improve fatty liver and related symptoms?

Sustained weight loss of 5 to 10 per cent of body weight, a Mediterranean-style diet, alcohol reduction, and at least 150 minutes of moderate aerobic exercise per week are the most evidence-based interventions for NAFLD, per NICE NG49.

Lifestyle changes can help reduce liver fat and slow the progression of NAFLD, but they complement rather than replace prompt clinical assessment if you have symptoms such as dark urine or jaundice.

Sustained weight loss through a balanced diet and regular physical activity is the most evidence-based intervention for improving NAFLD. NICE guidance (NG49) emphasises achieving meaningful percentage weight loss (typically 5 to 10 per cent of body weight) and avoiding rapid weight loss, which can paradoxically worsen liver inflammation.^[1] NHS weight-loss guidance suggests that a gradual rate of around 0.5 to 1 kg per week is generally safe for most people, though the appropriate target should be agreed with a clinician. A Mediterranean-style diet, rich in vegetables, wholegrains, oily fish, and unsaturated fats, has been associated with reduced liver fat and improved metabolic markers in clinical studies.^[18][19]

Alcohol reduction or abstinence is essential, even in non-alcoholic fatty liver disease, because alcohol places additional strain on a liver that is already under metabolic stress. NHS alcohol guidelines recommend keeping intake below 14 units per week, spread across several days, with alcohol-free days included.^[3][4] For those with alcoholic liver disease, complete abstinence is strongly advised and specialist support may be needed.

Regular aerobic exercise, such as brisk walking, cycling, or swimming, is recommended for at least 150 minutes per week at moderate intensity, in line with the UK Chief Medical Officers' Physical Activity Guidelines.^[8][9] This helps reduce liver fat independently of weight loss. Resistance training also shows benefit. Managing associated conditions, including type 2 diabetes, high blood pressure, and raised cholesterol, is equally important, as these accelerate liver fibrosis.

For people considering structured weight management support, a range of options exists, including NHS Tier 3 weight management services, where available through your local Integrated Care Board (ICB). Access and eligibility criteria vary by area. Where clinically appropriate, pharmacological treatment may also be considered following a consultation with a clinician. Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations with prescriber review and pharmacist support; any treatment is only prescribed where a clinician judges it appropriate for an individual's circumstances. Regardless of the route chosen, regular monitoring of liver function through your GP remains central to safe, long-term management.

Relevant UK sources: NICE NG49 (NAFLD: assessment and management); NHS weight-loss advice; UK Chief Medical Officers' Physical Activity Guidelines; NHS alcohol units guidance; British Liver Trust patient resources.

Scientific References

1. Metabolic dysfunction-associated steatotic liver disease (MASLD): assessment and management (NG49).
2. Suspected cancer: recognition and referral (NG12).
3. Alcohol units.
4. The risks of drinking too much.
5. Tips to help you lose weight.
6. Overweight and obesity in adults.
7. Physical activity guidelines for adults aged 19 to 64.
8. Physical activity guidelines: UK Chief Medical Officers' report.
9. UK Chief Medical Officers' physical activity guidelines (full text).
10. Primary biliary cholangitis – symptoms.
11. Cholestasis – treatment summary.
12. Hoilat GJ et al. Bilirubinuria. StatPearls [Internet]..
13. Garden JM. Pruritus in hepatic cholestasis: pathogenesis and therapy..
14. Kremer AE et al. Cholestatic pruritus: a review of pathophysiology, clinical manifestations, and therapeutic landscape..
15. The scientific basis of cholestatic liver disease and its symptom complex..
16. Hallsworth K et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss..
17. Keating SE et al. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis..
18. Adherence to a 'MediterrAsian' diet is associated with weight loss-independent improvements in liver fat and lipid profile: secondary analysis of a randomized controlled trial..
19. Tsaban G et al. Novel proteomic signatures may indicate MRI-assessed intrahepatic fat state and changes: The DIRECT PLUS clinical trial..
20. Exploring the role of extra virgin olive oil (EVOO) in MASLD: evidence from human consumption..

Frequently Asked Questions